GILD Stock Price, Chart, Stats & News

Gilead Sciences, Inc.
Save
GILD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 80.80% |
Operating margin | 37.37% |
Pretax margin | 33.28% |
Net margin | 28.90% |
Effective tax rate | 13.13% |
ROA | 14.42% |
ROE | 41.01% |
D/E | 1.09x |
Interest coverage ratio | 10.73x |
GILD valuation
P/E | 14.92x |
P/S | 5.66x |
P/B | 7.37x |
P/CF | 16.64x |
P/FCF | 17.63x |
P/OCF | 16.64x |
PEG | 3.87x |
EV multiple | 11.60x |
About
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions.
Similar securities
Based on sector and market capitalization
Report issue










